Key result
High C-reactive protein-to-albumin ratio is linked to ~78% higher all-cause mortality in acute heart failure.
Why the study?
The study was conducted to evaluate the correlation between the high-sensitivity C-reactive protein-to-albumin ratio and all-cause mortality in patients with acute exacerbation of chronic heart failure.
Does a higher high-sensitivity C-reactive protein-to-albumin ratio (CAR) predict increased all-cause mortality in patients with acute exacerbation of chronic heart failure?
Cohort (n=342)
No
Does a higher high-sensitivity C-reactive protein-to-albumin ratio (CAR) predict increased all-cause mortality in patients with acute exacerbation of chronic heart failure?
Hazard Ratio: 1.778 (95% CI 1.092–2.894)
Absolute Event Rate: 43.1% vs 25.1%
p-value: p=0.021
An elevated high-sensitivity C-reactive protein-to-albumin ratio is an independent predictor of all-cause mortality in patients with acute exacerbation of chronic heart failure.
May aid risk stratification in acute HF exacerbation; extends CAR data but leaves open added value pending prospective validation.
OBJECTIVE: To evaluate the correlation between the high-sensitivity C-reactive protein-to-albumin ratio (CAR) and all-cause mortality in patients with acute exacerbation of chronic heart failure (AECHF). METHODS: In this retrospective cohort study, 342 patients were enrolled from the First People's Hospital of Zhenjiang City between January 1, 2020, and December 31, 2025. Cox regression analyses, subgroup analyses, Kaplan-Meier survival curves, and receiver operating characteristic (ROC) analyses were employed to assess the association between CAR and all-cause mortality. RESULTS: During a median follow-up period of 16.35 months, 95 patients (27.8%) died. Multivariate Cox regression analysis revealed that each unit increase and each standard deviation increase in CAR were associated with a 41.2% and 40.7% increased risk of all-cause mortality, respectively (HR: 1.412, 95% CI: 1.221-1.633; HR: 1.407, 95% CI: 1.219-1.625). The risk of all-cause mortality in the high CAR group was 1.778 times that of the low CAR group (HR: 1.778; 95% CI: 1.092-2.894). The robustness of the association between CAR and all-cause mortality was further corroborated by subgroup and sensitivity analyses (p < 0.05). Kaplan-Meier survival curves revealed significant survival differences across CAR subgroups, with markedly lower cumulative survival observed in the high-CAR group (p < 0.05). ROC curve indicated a weak but statistically significant predictive value for all-cause mortality risk (p = 0.025). CONCLUSION: Higher levels of CAR are associated with a higher risk of all-cause mortality in AECHF patients.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) conducted a cohort in Acute exacerbation of chronic heart failure (AECHF) (n=342). High C-reactive protein-to-albumin ratio (CAR > 0.66) vs. Low C-reactive protein-to-albumin ratio (CAR ≤ 0.66) was evaluated on All-cause mortality (HR 1.778, 95% CI 1.092-2.894, p=0.021). A high C-reactive protein-to-albumin ratio (>0.66) was independently associated with a 1.778-fold increased risk of all-cause mortality compared to a low ratio in patients with acute exacerbation of chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: